Heiko Schuster

4.9k total citations
46 papers, 1.4k citations indexed

About

Heiko Schuster is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Heiko Schuster has authored 46 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Immunology and 21 papers in Oncology. Recurrent topics in Heiko Schuster's work include Immunotherapy and Immune Responses (24 papers), vaccines and immunoinformatics approaches (17 papers) and CAR-T cell therapy research (8 papers). Heiko Schuster is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), vaccines and immunoinformatics approaches (17 papers) and CAR-T cell therapy research (8 papers). Heiko Schuster collaborates with scholars based in Germany, Switzerland and United States. Heiko Schuster's co-authors include Stefan Stevanović, Hans‐Georg Rammensee, Daniel J. Kowalewski, Étienne Caron, Linus Backert, Lutz F. Tietze, Theo Sturm, Lothar Kanz, Ching Chiek Koh and Ingrid Schuberth and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Heiko Schuster

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heiko Schuster Germany 24 839 802 539 235 136 46 1.4k
Penelope M. Drake United States 24 511 0.6× 896 1.1× 649 1.2× 597 2.5× 250 1.8× 33 1.9k
Shrikant Deshpande United States 18 358 0.4× 457 0.6× 600 1.1× 606 2.6× 111 0.8× 57 1.4k
Sunil K. Chatterjee United States 22 688 0.8× 788 1.0× 448 0.8× 362 1.5× 75 0.6× 58 1.5k
Elliot C. Woods United States 10 467 0.6× 885 1.1× 186 0.3× 184 0.8× 237 1.7× 14 1.3k
Silvia Crescioli United Kingdom 17 450 0.5× 625 0.8× 464 0.9× 625 2.7× 27 0.2× 33 1.3k
Mads A. Tarp Denmark 12 553 0.7× 1.3k 1.6× 238 0.4× 499 2.1× 449 3.3× 12 1.6k
Kevin L. Bicker United States 16 373 0.4× 654 0.8× 168 0.3× 107 0.5× 129 0.9× 21 1.1k
Shangzi Wang United States 10 480 0.6× 522 0.7× 502 0.9× 445 1.9× 26 0.2× 16 1.2k
Miyako Abe United States 17 482 0.6× 1.3k 1.6× 473 0.9× 624 2.7× 126 0.9× 20 1.7k
Ola M. Saad United States 23 258 0.3× 896 1.1× 1.1k 2.1× 1.2k 5.0× 192 1.4× 45 2.1k

Countries citing papers authored by Heiko Schuster

Since Specialization
Citations

This map shows the geographic impact of Heiko Schuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heiko Schuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heiko Schuster more than expected).

Fields of papers citing papers by Heiko Schuster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heiko Schuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heiko Schuster. The network helps show where Heiko Schuster may publish in the future.

Co-authorship network of co-authors of Heiko Schuster

This figure shows the co-authorship network connecting the top 25 collaborators of Heiko Schuster. A scholar is included among the top collaborators of Heiko Schuster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heiko Schuster. Heiko Schuster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kubiniok, Peter, Ana Marcu, Leon Bichmann, et al.. (2022). Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues. iScience. 25(2). 103768–103768. 25 indexed citations
2.
Fritsche, Jens, Daniel J. Kowalewski, Frederik Gwinner, et al.. (2021). Pitfalls in HLA Ligandomics—How to Catch a Li(e)gand. Molecular & Cellular Proteomics. 20. 100110–100110. 18 indexed citations
3.
Quass, Petra, Annika Nelde, Heiko Schuster, et al.. (2021). Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo. Cancer Immunology Immunotherapy. 70(10). 3055–3055. 1 indexed citations
5.
Quass, Petra, Annika Nelde, Heiko Schuster, et al.. (2020). Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo. Cancer Immunology Immunotherapy. 69(7). 1217–1227. 5 indexed citations
6.
Löffler, Markus, Daniel J. Kowalewski, Linus Backert, et al.. (2018). Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation. Cancer Research. 78(16). 4627–4641. 36 indexed citations
7.
Schuster, Heiko, Wenguang Shao, Tobias Weiß, et al.. (2018). A tissue-based draft map of the murine MHC class I immunopeptidome. Scientific Data. 5(1). 180157–180157. 42 indexed citations
8.
Marco, Moreno Di, Heiko Schuster, Linus Backert, et al.. (2017). Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices. The Journal of Immunology. 199(8). 2639–2651. 68 indexed citations
9.
Löffler, Markus, Heiko Schuster, Anne Zeck, et al.. (2017). Pharmacodynamics of Oxaliplatin-Derived Platinum Compounds During Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Emerging Aspect Supporting the Rational Design of Treatment Protocols. Annals of Surgical Oncology. 24(6). 1650–1657. 8 indexed citations
10.
Oehl, Kathrin, Daniel J. Kowalewski, Moreno Di Marco, et al.. (2016). Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy. PLoS ONE. 11(11). e0167017–e0167017. 17 indexed citations
11.
Kowalewski, Daniel J., Juliane S. Walz, Linus Backert, et al.. (2016). Carfilzomib alters the HLA-presented peptidome of myeloma cells and impairs presentation of peptides with aromatic C-termini. Blood Cancer Journal. 6(4). e411–e411. 14 indexed citations
12.
Klatt, Martin G., Daniel J. Kowalewski, Heiko Schuster, et al.. (2016). Carcinogenesis of renal cell carcinoma reflected in HLA ligands: A novel approach for synergistic peptide vaccination design. OncoImmunology. 5(8). e1204504–e1204504. 15 indexed citations
13.
Caron, Étienne, et al.. (2015). Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry*. Molecular & Cellular Proteomics. 14(12). 3105–3117. 163 indexed citations
14.
Berlin, Claudia, Daniel J. Kowalewski, Heiko Schuster, et al.. (2014). Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy. Leukemia. 29(3). 647–659. 95 indexed citations
15.
Peper-Gabriel, Janet K., Heiko Schuster, Markus Löffler, et al.. (2014). An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells. Journal of Immunological Methods. 405. 192–198. 62 indexed citations
16.
Schuster, Heiko, Balakumar Vijayakrishnan, & Benjamin G. Davis. (2014). Chain-growth polyglycosylation: synthesis of linker-equipped mannosyl oligomers. Carbohydrate Research. 403. 135–141. 12 indexed citations
17.
Tietze, Lutz F., et al.. (2010). Atropisomerism of Aromatic Carbamates. Chemistry - A European Journal. 16(42). 12678–12682. 8 indexed citations
18.
Schuster, Heiko, Birgit Krewer, Jana Hof, et al.. (2010). Synthesis of the first spacer containing prodrug of a duocarmycin analogue and determination of its biological activity. Organic & Biomolecular Chemistry. 8(8). 1833–1833. 25 indexed citations
19.
Manguro, Lawrence Onyango Arot, et al.. (2009). A new sterol diglycoside from Conyza floribunda. South African Journal of Chemistry. 62(1). 163–167. 8 indexed citations
20.
Tietze, Lutz F., Birgit Krewer, Michael Müller, et al.. (2008). Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer Therapy. ChemMedChem. 3(12). 1946–1955. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026